You are here

Ipsen

FDA approves Cabometyx for liver cancer

BioCentury

Mon, 01/14/19 - 11:59 pm

With New HQ, Ipsen to Rapidly Expand North American Presence

BioSpace

Sat, 11/17/18 - 12:59 pm

Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma

CP WIre

Fri, 09/21/18 - 10:02 am

hepatocellular carcinoma

Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma

Fri, 09/21/18 - 10:01 am

hepatocellular carcinoma

Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma

CP Wire

Wed, 09/19/18 - 11:27 am

renal cell carcinoma

Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma

Wed, 09/19/18 - 09:16 am

Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs

Endpoints

Thu, 06/7/18 - 10:50 pm

Exelixis and Ipsen Announce European Approval of Cabometyx for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma

Thu, 05/17/18 - 09:42 am

advanced renal cell carcinoma

renal cell carcinoma

Ipsen focuses on oncology to keep growing

GoInPharma

Mon, 09/18/17 - 09:24 am

Ipsen wins approval for gastroenteropancreatic neuroendocrine tumor drug

Mass Device

Tue, 07/4/17 - 11:05 pm

gastroenteropancreatic neuroendocrine tumor

Sanofi Sells 5 Over-the-Counter Drugs for $88M

Investopedia

Tue, 02/14/17 - 09:20 am

France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal

Yahoo/Reuters

Mon, 01/9/17 - 09:54 am

Merrimack Pharmaceuticals

pancreatic cancer

Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX™ (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO

Yahoo

Sun, 06/5/16 - 11:59 am

clinical trials

advanced renal cell carcinoma

Ipsen to Step Up Deal-Making, Scout for New Cancer Products

Bloomberg

Tue, 01/19/16 - 04:27 pm

Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push

Fierce Pharma Marketing

Wed, 11/26/14 - 11:50 am

Nestle’s Galderma Deepens Ipsen Alliance for Wrinkle Smoother

Bloomberg

Fri, 07/11/14 - 08:32 am

China Drug Probe Leads to Tougher Market, Ipsen CEO Says

Bloomberg

Fri, 08/30/13 - 09:28 am

Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech

Fierce Biotech

Thu, 01/24/13 - 11:32 am

Baxter International

Roche Said to Return Diabetes Drug Rights to Ipsen

Bloomberg

Tue, 02/1/11 - 08:25 am

The Top 10 Phase III Failures of 2010

Fierce Biotech

Fri, 10/22/10 - 11:36 am

Pages